title: [Reduction of Ph1 chromosome in atypical myeloproliferative disorder by intensive chemotherapy].
authors.forename: H
authors.initials: H
authors.lastname: Takeyama
authors.forename: K
authors.initials: K
authors.lastname: Yano
authors.forename: H
authors.initials: H
authors.lastname: Fukutani
authors.forename: F
authors.initials: F
authors.lastname: Yamamoto
authors.forename: E
authors.initials: E
authors.lastname: Watanabe
authors.forename: T
authors.initials: T
authors.lastname: Satake
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D015376:Nimustine; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D010677:Philadelphia Chromosome
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D015376:Nimustine